EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
70 hedge funds and large institutions have $230M invested in ESSA Pharma in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
+10
Holders Change %
+16.67%
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
22
Reduced
14
Closed
9
Calls
$146K
Puts
$2K
Net Calls
+$144K
Net Calls Change
-$18K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$9.55M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$5.26M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$5.22M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$4.32M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.03M |
Top Sellers
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
-$12.3M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$10.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.49M |
| 4 |
Blackstone Inc
New York
|
-$8.03M |
| 5 |
FM
Frazier Management
Seattle,
Washington
|
-$7.72M |
